Is gabapentin good for anxiety
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Anxiety: An Overview of Current Research
Introduction to Gabapentin and Its Uses
Gabapentin, originally developed as an anticonvulsant, has found a variety of off-label uses in the treatment of psychiatric disorders, including anxiety. Despite its widespread use, the evidence supporting gabapentin's efficacy for anxiety disorders is mixed and often limited to small-scale studies and anecdotal reports.
Gabapentin's Efficacy in Treating Anxiety Disorders
General Findings on Anxiety
Several studies have explored gabapentin's potential in treating various forms of anxiety. A systematic review concluded that gabapentin appears to be effective in treating certain anxiety disorders, such as preoperative anxiety, anxiety in breast cancer survivors, and social phobia1. Another review highlighted that gabapentin might be beneficial for anxiety, although the evidence is not robust enough to support its use as a monotherapy8.
Specific Anxiety Disorders
Generalized Anxiety Disorder (GAD)
The evidence for gabapentin's effectiveness in treating Generalized Anxiety Disorder (GAD) is sparse. One case report indicated a positive dose-response relationship in a patient with GAD, suggesting potential benefits, but emphasized the need for more controlled studies9. Another review noted the absence of randomized controlled trials (RCTs) specifically for GAD, indicating a gap in the research8.
Social Anxiety Disorder and Panic Disorder
Gabapentin has shown some promise in treating social anxiety disorder. A study involving breast cancer survivors found that gabapentin significantly reduced anxiety symptoms compared to a placebo, with the lower dose (300 mg) being particularly effective6. However, its efficacy in treating panic disorder is less clear, with some studies indicating no significant benefit7.
Comparative Studies and Meta-Analyses
A systematic review and meta-analysis protocol aimed to evaluate the efficacy and tolerability of gabapentin and pregabalin in treating anxiety, bipolar disorder, and insomnia. This review intends to provide a comprehensive analysis of available RCTs, but the results are pending2. Another review comparing gabapentin and pregabalin noted that while pregabalin is approved for GAD in Europe, gabapentin is often used off-label for various anxiety disorders, especially when other treatments fail5.
Safety and Tolerability
Gabapentin is generally well-tolerated, with a favorable side effect profile and minimal drug interactions, making it an attractive option for patients who may not tolerate other anxiolytics well3 4. This safety profile is particularly beneficial for patients with a history of substance use, as gabapentin does not carry the same risk of addiction as benzodiazepines6.
Conclusion
While gabapentin shows potential in treating certain anxiety disorders, the current evidence is not strong enough to recommend it as a first-line treatment. It may be more effective as an adjunctive therapy rather than a monotherapy. More extensive and well-designed clinical trials are needed to better understand its efficacy and safety in treating anxiety disorders. For now, gabapentin remains a viable option for patients who do not respond to traditional anxiolytics or who are at risk of substance abuse.
Sources and full results
Most relevant research papers on this topic
Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review
Gabapentin shows potential in treating anxiety disorders and alcohol dependence, but more clinical trials are needed to confirm its effectiveness and safety.
Systematic ReviewBiological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis
This systematic review aims to assess the efficacy and tolerability of gabapentin and pregabalin in treating bipolar disorder, insomnia, and anxiety, aiming to inform future treatment strategies.
Meta-Analysis
Rigorous JournalGabapentin: A Review of Published Experience in the Treatment of Bipolar Disorder and Other Psychiatric Conditions
Gabapentin shows potential in treating bipolar disorder, anxiety disorders, behavioral dyscontrol, and substance use disorders, but more well-designed studies are needed to confirm its effectiveness as monotherapy and as an adjunctive treatment with other mood stabilizers.
Systematic ReviewGabapentin and Anxiety
Gabapentin is an effective and minimally side effects alternative for treating anxiety disorders, both with and without concurrent depression.
Gabapentin and Pregabalin for the Treatment of Anxiety Disorders
Both gabapentin and pregabalin show potential in treating primary anxiety disorders, particularly those not responsive to antidepressants and benzodiazepines.
Very Rigorous JournalA randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors
Gabapentin 300 and 900 mg effectively reduce anxiety symptoms in breast cancer survivors, offering a low-cost alternative for both anxiety and hot flashes treatment.
RCT
Large Human TrialRigorous JournalAre gabapentin-related medications effective in reducing anxiety symptoms in adults with anxiety disorders?
Pregabalin therapy shows small reductions in generalized anxiety disorder symptoms, but is not clinically significant; gabapentin may improve social phobia and anxiety in breast cancer patients.
Meta-AnalysisGabapentin Therapy in Psychiatric Disorders: A Systematic Review.
Gabapentin may have benefits for some anxiety disorders and may help with alcohol cravings and opioid dependence, but more research is needed to clarify its effectiveness in other psychiatric disorders.
Systematic ReviewTreatment of Generalized Anxiety Disorder with Gabapentin
Gabapentin shows a clear dose-response pattern in reducing generalized anxiety disorder symptoms, offering potential for effective treatment in the absence of controlled studies.
Case ReportEffect of gabapentin on anxiety among 306 breast cancer patients: A URCC CCOP study.
Gabapentin 300mg effectively reduces anxiety in breast cancer patients, while 900mg and placebo increase anxiety in patients experiencing 2 hot flashes a day.
RCTLarge Human Trial